Skip to main content
. 2016 Mar 7;95(9):e2702. doi: 10.1097/MD.0000000000002702

FIGURE 1.

FIGURE 1

Changes in PROs in Asian patients by treatment week 4 with sofosbuvir-containing regimens. The PROs are normalized to a 0%–100% scale. Average across all 26 PROs: −7.4% (min −19.5%, max +1.9%) in RBV ± IFN (+SOF); +2.8% (min −3.0%, max +12.2%) in LDV/SOF.